Background The purpose of this study was to identify prognostic parameters for patients with
follicular lymphoma (FL) in first progression/relapse. These would be useful for selection of …

Background and objectives: Patients with follicular lymphoma (FL) in advanced stages are
currently deemed incurable with standard treatments. However, FL is considered to be …

Background Follicular lymphoma is the second most common non-Hodgkin lymphoma in the
United States and Europe. However, most of the prospective randomized studies have very …

Background Different prognostic scores have been proposed to predict the outcome of
follicular lymphoma (FL) patients at diagnosis. A new prognostic index specifically …

Follicular lymphoma (FL) is generally considered an indolent disorder. With modern day
treatments, long remissions are often achieved both in the front-line and relapsed setting …

Purpose Advanced-stage follicular lymphoma is considered incurable. The pace of
improvements in treatment has been slow. This article analyzes five sequential cohorts of …

Follicular lymphoma (FL) is considered an indolent but incurable disease. It remains to be
clarified whether the outcome has changed after the recent introduction of novel treatment …

Although the introduction of immunotherapy has improved outcomes for follicular lymphoma
(FL) patients, histological transformation (HT) and early relapse still confer a poor prognosis …

Background The natural history of follicular lymphoma is believed not to have changed over
the last 30 years. Median survivals have ranged from 7 to 10 years, and the disease is …

Follicular lymphoma (FL) is a heterogeneous disease. For many it is experienced as a
chronic, relapsing, indolent condition with long overall survival (OS). Most people affected …